Hypoglycorrhachia in adults with community-acquired meningitis: etiologies and prognostic significance

• Main Authors: Vandana Shrikanth, Lucrecia Salazar, Nabil Khoury, Susan Wootton, Rodrigo Hasbun
• Format: Article
• Language: English
• Published: Elsevier 2015-10-01
• Series: International Journal of Infectious Diseases
• Subjects: Hypoglycorrhachia; Meningitis; Prognosis
• Online Access: http://www.sciencedirect.com/science/article/pii/S1201971215001964
• ISSN: 1201-9712; 1878-3511

Objectives: Hypoglycorrhachia (cerebrospinal fluid (CSF) glucose <45 mg/dl) has been identified as a prognostic factor in patients with meningitis. The differential diagnosis of hypoglycorrhachia and its clinical significance was analyzed in the present study. Methods: This was a retrospective study of 620 adult patients with community-acquired meningitis (CSF white blood cell count >5 × 106 cells/l and absence of a CSF shunt or recent neurosurgical procedure (<1 month)) at eight Memorial Hermann hospitals in Houston, Texas, from January 2005 to December 2010. An adverse clinical outcome was defined as a Glasgow outcome scale score of ≤4. Results: Out of 620 patients with meningitis, 116 (19%) had hypoglycorrhachia. Etiologies of hypoglycorrhachia were idiopathic (n = 40), bacterial (n = 27), cryptococcal (n = 26), viral (n = 15), and tuberculous (n = 4). Patients with hypoglycorrhachia were more likely to be immunosuppressed, have a history of intravenous drug use, and present with a vesicular or petechial rash, nausea or vomiting, nuchal rigidity, sinusitis/otitis, abnormal mental status, and focal neurological deficits compared to those patients without hypoglycorrhachia (p < 0.05). Additionally, patients in the hypoglycorrhachia group had significantly higher rates of positive CSF and blood cultures, urgent treatable conditions, and abnormal cranial imaging (p < 0.05). Furthermore, patients with hypoglycorrhachia had more adverse clinical outcomes (26/116 (22.4%) vs. 45/504 (8.9%); p < 0.001). Conclusion: Hypoglycorrhachia has significant clinical and prognostic value in the evaluation of adult patients with community-acquired meningitis.